𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.

✍ Scribed by JC Daubresse; D Daigneux; M Bruwier; A Luyckx; PJ Lefebvre

Book ID
117941997
Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
754 KB
Volume
7
Category
Article
ISSN
0306-5251

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of a new oral hypoglycaemic agen
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM
✍ B. H. R. Wolffenbuttel; L. Nijst; J. P. J. E. Sels; P. P. C. A. Menheere; P. G. πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 396 KB

We have evaluated the effects of repaglinide, a new non-sulphonylurea oral hypoglycaemic agent that has a stimulatory effect on insulin secretion. Forty-four patients with NIDDM, already treated with a sulphonylurea, took part in an open, randomised, group comparison study of 12 weeks duration, duri

Multicentre study to assess quality of l
Multicentre study to assess quality of life and glycaemic control of Type 2 diabetic patients treated with insulin compared with oral hypoglycaemic agents
✍ Barnett, AH ;Jones, D Bowen ;Burden, AC ;Janes, JM ;Sinclair, A ;Small, M ;Tinda πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 530 KB

## Abstract Quality of life, glycaemic control and frequency of hypoglycaemia were compared in 93 moderate to poorly controlled Type 2 diabetes patients randomly allocated to one of three treatment groups: Group A continued on oral hypoglycaemics, Group B switched to twice‐daily fixed mixture of hu